Clinicopathological features of 171 cases of primary thyroid lymphoma

A long-term study involving 24553 patients with Hashimoto's disease

Natsuko Watanabe, Jaeduk Y. Noh, Hiroto Narimatsu, Kengo Takeuchi, Takuhiro Yamaguchi, Kaori Kameyama, Kazuhiko Kobayashi, Masahiro Kami, Atsushi Kubo, Yo Kunii, Taeko Shimizu, Koji Mukasa, Fumiko Otsuka, Ayako Miyara, Akinobu Minagawa, Koichi Ito, Kunihiko Ito

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

There are few large-scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24553 patients with Hashimoto's disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67years (range, 27-90years). The pathological diagnosis of PTL patients included diffuse large B-cell lymphoma (DLBCL) (n=74), DLBCL with mucosa-associated lymphoid tissue (MALT) lymphoma (n=13), MALT lymphoma (n=80) and others (n=4). Of the 167 patients with B-cell lymphoma, treatment included combined modality therapy (CMT) (n=95), radiation therapy (RT) alone (n=60) and chemotherapy alone (n=6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97%) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5-year overall survival rate was 85% (95% confidence interval, 79-91%). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.

Original languageEnglish
Pages (from-to)236-243
Number of pages8
JournalBritish Journal of Haematology
Volume153
Issue number2
DOIs
Publication statusPublished - 2011 Apr

Fingerprint

Hashimoto Disease
Lymphoma
Thyroid Gland
Marginal Zone B-Cell Lymphoma
Combined Modality Therapy
Radiotherapy
Therapeutics
Drug Therapy
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
B-Lymphocytes
Survival Rate
Confidence Intervals

Keywords

  • Chemotherapy
  • Clinical stage
  • Diffuse large B-cell lymphoma
  • Irradiation
  • Mucosa-associated-lymphoid tissue

ASJC Scopus subject areas

  • Hematology

Cite this

Clinicopathological features of 171 cases of primary thyroid lymphoma : A long-term study involving 24553 patients with Hashimoto's disease. / Watanabe, Natsuko; Noh, Jaeduk Y.; Narimatsu, Hiroto; Takeuchi, Kengo; Yamaguchi, Takuhiro; Kameyama, Kaori; Kobayashi, Kazuhiko; Kami, Masahiro; Kubo, Atsushi; Kunii, Yo; Shimizu, Taeko; Mukasa, Koji; Otsuka, Fumiko; Miyara, Ayako; Minagawa, Akinobu; Ito, Koichi; Ito, Kunihiko.

In: British Journal of Haematology, Vol. 153, No. 2, 04.2011, p. 236-243.

Research output: Contribution to journalArticle

Watanabe, N, Noh, JY, Narimatsu, H, Takeuchi, K, Yamaguchi, T, Kameyama, K, Kobayashi, K, Kami, M, Kubo, A, Kunii, Y, Shimizu, T, Mukasa, K, Otsuka, F, Miyara, A, Minagawa, A, Ito, K & Ito, K 2011, 'Clinicopathological features of 171 cases of primary thyroid lymphoma: A long-term study involving 24553 patients with Hashimoto's disease', British Journal of Haematology, vol. 153, no. 2, pp. 236-243. https://doi.org/10.1111/j.1365-2141.2011.08606.x
Watanabe, Natsuko ; Noh, Jaeduk Y. ; Narimatsu, Hiroto ; Takeuchi, Kengo ; Yamaguchi, Takuhiro ; Kameyama, Kaori ; Kobayashi, Kazuhiko ; Kami, Masahiro ; Kubo, Atsushi ; Kunii, Yo ; Shimizu, Taeko ; Mukasa, Koji ; Otsuka, Fumiko ; Miyara, Ayako ; Minagawa, Akinobu ; Ito, Koichi ; Ito, Kunihiko. / Clinicopathological features of 171 cases of primary thyroid lymphoma : A long-term study involving 24553 patients with Hashimoto's disease. In: British Journal of Haematology. 2011 ; Vol. 153, No. 2. pp. 236-243.
@article{84a8a2ccb1ce4cb48a689ad79a3cbe2e,
title = "Clinicopathological features of 171 cases of primary thyroid lymphoma: A long-term study involving 24553 patients with Hashimoto's disease",
abstract = "There are few large-scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24553 patients with Hashimoto's disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67years (range, 27-90years). The pathological diagnosis of PTL patients included diffuse large B-cell lymphoma (DLBCL) (n=74), DLBCL with mucosa-associated lymphoid tissue (MALT) lymphoma (n=13), MALT lymphoma (n=80) and others (n=4). Of the 167 patients with B-cell lymphoma, treatment included combined modality therapy (CMT) (n=95), radiation therapy (RT) alone (n=60) and chemotherapy alone (n=6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97{\%}) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5-year overall survival rate was 85{\%} (95{\%} confidence interval, 79-91{\%}). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.",
keywords = "Chemotherapy, Clinical stage, Diffuse large B-cell lymphoma, Irradiation, Mucosa-associated-lymphoid tissue",
author = "Natsuko Watanabe and Noh, {Jaeduk Y.} and Hiroto Narimatsu and Kengo Takeuchi and Takuhiro Yamaguchi and Kaori Kameyama and Kazuhiko Kobayashi and Masahiro Kami and Atsushi Kubo and Yo Kunii and Taeko Shimizu and Koji Mukasa and Fumiko Otsuka and Ayako Miyara and Akinobu Minagawa and Koichi Ito and Kunihiko Ito",
year = "2011",
month = "4",
doi = "10.1111/j.1365-2141.2011.08606.x",
language = "English",
volume = "153",
pages = "236--243",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Clinicopathological features of 171 cases of primary thyroid lymphoma

T2 - A long-term study involving 24553 patients with Hashimoto's disease

AU - Watanabe, Natsuko

AU - Noh, Jaeduk Y.

AU - Narimatsu, Hiroto

AU - Takeuchi, Kengo

AU - Yamaguchi, Takuhiro

AU - Kameyama, Kaori

AU - Kobayashi, Kazuhiko

AU - Kami, Masahiro

AU - Kubo, Atsushi

AU - Kunii, Yo

AU - Shimizu, Taeko

AU - Mukasa, Koji

AU - Otsuka, Fumiko

AU - Miyara, Ayako

AU - Minagawa, Akinobu

AU - Ito, Koichi

AU - Ito, Kunihiko

PY - 2011/4

Y1 - 2011/4

N2 - There are few large-scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24553 patients with Hashimoto's disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67years (range, 27-90years). The pathological diagnosis of PTL patients included diffuse large B-cell lymphoma (DLBCL) (n=74), DLBCL with mucosa-associated lymphoid tissue (MALT) lymphoma (n=13), MALT lymphoma (n=80) and others (n=4). Of the 167 patients with B-cell lymphoma, treatment included combined modality therapy (CMT) (n=95), radiation therapy (RT) alone (n=60) and chemotherapy alone (n=6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97%) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5-year overall survival rate was 85% (95% confidence interval, 79-91%). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.

AB - There are few large-scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24553 patients with Hashimoto's disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67years (range, 27-90years). The pathological diagnosis of PTL patients included diffuse large B-cell lymphoma (DLBCL) (n=74), DLBCL with mucosa-associated lymphoid tissue (MALT) lymphoma (n=13), MALT lymphoma (n=80) and others (n=4). Of the 167 patients with B-cell lymphoma, treatment included combined modality therapy (CMT) (n=95), radiation therapy (RT) alone (n=60) and chemotherapy alone (n=6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97%) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5-year overall survival rate was 85% (95% confidence interval, 79-91%). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.

KW - Chemotherapy

KW - Clinical stage

KW - Diffuse large B-cell lymphoma

KW - Irradiation

KW - Mucosa-associated-lymphoid tissue

UR - http://www.scopus.com/inward/record.url?scp=79953078052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953078052&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2011.08606.x

DO - 10.1111/j.1365-2141.2011.08606.x

M3 - Article

VL - 153

SP - 236

EP - 243

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -